CEPI – VBI, COVID-19 Vaccine Development Funding Agreement Post author:GHIAA Admin Post published:December 12, 2022 Post category: Continue ReadingCEPI – VBI, COVID-19 Vaccine Development Funding Agreement
UnitaidExplore Sample Funding Terms and Conditions Post author:GHIAA Admin Post published:December 1, 2022 Post category: Continue ReadingUnitaidExplore Sample Funding Terms and Conditions
Gates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement Post author:GHIAA Admin Post published:November 8, 2022 Post category: Continue ReadingGates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement
Wellcome Trust – PTC Therapeutics, Cancer Treatment Research Funding Agreement Post author:GHIAA Admin Post published:October 25, 2022 Post category: Continue ReadingWellcome Trust – PTC Therapeutics, Cancer Treatment Research Funding Agreement
AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement Post author:GHIAA Admin Post published:September 13, 2022 Post category: Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement
Gates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement Post author:GHIAA Admin Post published:August 11, 2022 Post category: Continue ReadingGates Foundation – Icosavax, COVID-19 Vaccine Grant Agreement
Gates Foundation – Icosavax, COVID-19 Vaccine Global Access and Price Commitments Agreement Post author:GHIAA Admin Post published:August 11, 2022 Post category: Continue ReadingGates Foundation – Icosavax, COVID-19 Vaccine Global Access and Price Commitments Agreement
Gates Foundation – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:April 25, 2022 Post category: Continue ReadingGates Foundation – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement
Gates Foundation – Arsanis RSV Monoclonal Antibodies Funding Agreement Post author:GHIAA Admin Post published:April 25, 2022 Post category: Continue ReadingGates Foundation – Arsanis RSV Monoclonal Antibodies Funding Agreement